Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4
@tamedoncol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#biomarker #cancerprognosis #lungcancer #oncology #openaccess